Institutional filer · SEC 13F · Q4 2024

Q Global Advisors, LLC

The reported 13F portfolio of Q Global Advisors, LLC (CIK 1469589) - top holdings, how concentrated the book is, and what changed last quarter.

$97K
Reported book
51
Positions
#359
of 360 filers

The verdict

Q Global Advisors, LLC runs a focused institutional book - $97K across 51 reported positions as of Q4 2024, a concentrated portfolio led by a few core positions.

$97K
reported 13F value
51
disclosed positions
31.1%
in ASCENDIS PHARMA A/S
#359
of 360 filers

Reflects long US-equity positions reported to the SEC as of Q4 2024; 13F excludes shorts, cash, non-US and most derivatives, so this is not total AUM.

How to read this page

This page reconstructs an institutional manager's reported equity portfolio from its quarterly SEC Form 13F-HR filings. Any investment manager with at least $100 million in qualifying US-listed equity assets must file a 13F with the Securities and Exchange Commission within 45 days of each quarter-end, disclosing the long positions it held on the last day of that quarter. The "reported book" shown here is the total market value of those disclosed positions, it is not the firm's total assets under management, because 13F covers only long US-listed equities and a defined set of options and convertibles. Short positions, cash, private holdings, sovereign debt, most fixed income, non-US equities, and derivatives are all excluded by rule, so a manager's true economic exposure can differ materially from what appears here. "Positions" counts the distinct securities disclosed; "% of book" shows how much weight each holding carries. Treat these figures as a quarter-lagged snapshot for understanding how a manager is positioned - not as live holdings or investment advice. Each line traces back to a specific filing on SEC EDGAR. This page is provided for informational purposes only and is not financial advice, consult a licensed financial advisor before making investment decisions.

Reported book

$97K

13F equity value

Positions

51

Disclosed securities

Top-5 weight

87%

Of reported book

Largest position

31.1%

ASCENDIS PHARMA A/

Concentrated book

Top-5 position weight

0%100%87%
Top-5 position weight
Share of the book in its 5 largest positions · Q4 2024
Top-5 position weight 86.8%

The five largest positions make up about 87% of Q Global Advisors, LLC's reported book as of Q4 2024.

Q Global Advisors, LLC's largest reported positions
  1. 1

    31.1% of book

  2. 2

    24.0% of book

  3. 3

    17.4% of book

  4. 4

    9.6% of book

  5. 5
    NICE LTD $5K

    4.7% of book

  6. 6

    4.1% of book

Top 6 of 51 positions by value · Q4 2024

Top Reported Holdings

# Security Value % of book
1 ASCENDIS PHARMA A/S $30K 31.1%
2 MODIVCARE INC $23K 24.0%
3 UNITED PARKS & RESORTS INC $17K 17.4%
4 TRANSDIGM GROUP INC $9K 9.6%
5 NICE LTD $5K 4.7%
6 ZOOM COMMUNICATIONS INC $4K 4.1%
7 ISHARES TR $2K 2.6%
8 HERBALIFE LTD $2K 2.5%
9 INVESCO EXCH TRADED FD TR II $2K 2.5%
10 COINCHECK GROUP NV $167 0.2%
11 AIRSHIP AI HLDGS INC $154 0.2%
12 GORILLA TECHNOLOGY GROUP INC $142 0.1%
13 REZOLVE AI LTD $138 0.1%
14 NEW ERA HELIUM INC $94 0.1%
15 SPECTRAL AI INC $76 0.1%
16 CLEANSPARK INC $72 0.1%
17 SK GROWTH OPPORTUNITIES CORP $67 0.1%
18 DMY SQUARED TECHNOLOGY GROUP $51 0.1%
19 MURANO GLOBAL INVTS PLC $48 0.1%
20 PSQ HOLDINGS INC $48 0.1%
21 HENNESSY CAPITAL INVST CORP $43 0.0%
22 FALCONS BEYOND GLOBAL INC $40 0.0%
23 SOUTHLAND HLDGS INC $39 0.0%
24 LANZATECH GLOBAL INC $30 0.0%
25 MONEYHERO LIMITED $25 0.0%

Latest Quarter Trades · Q4 2024

Reading Q Global Advisors, LLC's book

A few core positions drive most of this book.

  • Open any holding to see who else owns it and how concentrated that stock is. Browse stocks
  • Compare this manager against the largest 13F filers by book size. Top funds by AUM
  • Remember 13F shows long positions only, not total AUM, shorts or non-US holdings. 13F limitations

Informational only, not investment advice. 13F is a 45-day-lagged quarterly snapshot; positions may have changed since the filing date.

Frequently Asked Questions

How big is Q Global Advisors, LLC's 13F portfolio?
Q Global Advisors, LLC reports $97K of long US-equity positions across 51 securities as of Q4 2024. This reflects 13F-disclosed holdings only, it is not the firm's total assets under management.
What is Q Global Advisors, LLC's largest position?
Q Global Advisors, LLC's largest reported position is ASCENDIS PHARMA A/S at $30K, about 31.1% of its reported book as of Q4 2024.
What did Q Global Advisors, LLC trade last quarter?
In its Q4 2024 filing, Q Global Advisors, LLC opened 50 new positions. Each change is drawn from a line in the firm's 13F-HR filing and can be verified on SEC EDGAR.
Where does Q Global Advisors, LLC's holdings data come from?
Every figure renders live from Q Global Advisors, LLC's SEC Form 13F-HR filings in EDGAR, a mandatory quarterly disclosure of long US-listed equity positions, filed within 45 days of quarter-end.

Source: U.S. Securities and Exchange Commission (SEC) - EDGAR Form 13F-HR institutional holdings filings · Q4 2024 13F-HR discloses long US-listed equity positions of managers with $100M+ qualifying assets, filed within 45 days of period end. Reported value is not total AUM.